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Résumé 
Objectifs : Le bruxisme survenant au cours du sommeil est un trouble du movement 
caractérisé par du grincement de dents et l’activité rythmique des muscles masticateurs 
(ARMM).  Le bruxisme/ARMM est souvent associé à des mouvements du corps et des à 
éveils corticaux.  Une séquence d’activation précède le ARMM/bruxisme.  Ces événements 
incluent une augmentation des variables suivants : l’activité sympathique (-4 minutes), les 
activités encéphalographique (-4 second), le fréquence cardiaque, l’amplitude de la 
respiration (-1 second) et l’activité des muscle suprahyoïdiens (-0.8 second).  La présente 
étude a examiné l’association entre le bruxisme et les changements de la pression artérielle. 
Méthodes: Dix sujets avec le bruxisme (5 hommes, 5 femmes, âge moyen = 26 ± 1,8) ont 
complétés 3 nuits de polysomnographie qui comprenait l'enregistrement non invasive de la 
pression artérielle. La première nuit a servi de dépistage et d’habituation au laboratoire. 
L'analyse a été réalisée sur les deuxièmes et troisièmes nuits enregistrements. Seuls les 
épisodes de  bruxisme isolés survenant au cours du stade 2 du sommeil ont été utilisés pour 
l’analyse, pour un total de 65 épisodes. Les mesures des pressions systolique et diastolique 
ont été prises 20 battements avant et 23 battements après l'apparition de chaque épisode 
bruxisme lors du sommeil. Les épisodes de bruxisme ont été classés comme suit: 
1) bruxisme avec éveil cortical; 2) bruxisme avec mouvement du corps (MC), 3) bruxisme 
avec éveil cortical et MC. Une quatrième catégorie, bruxisme seul, a également été 
analysée, mais utilisée comme donnée préliminaire puisque la catégorie se composait de 
seulement 4 épisodes de bruxisme. 
Résultats: Les deux pressions systolique et diastolique ont augmenté avec les épisodes de 
bruxisme. Cette augmentation a été statistiquement significative pour la pression systolique 
et diastolique pour les épisodes de bruxisme avec éveil cortical et/ou MC (p ≤ 0,05). 
L’augmentation moyenne de la pression (systolique / diastolique ± SE) a été : 28,4 ± 
2,4/13,2 ± 1,5 mm Hg pour le bruxisme avec éveil cortical; 30,7 ± 1,6/19.4 ± 2.3 mm Hg 
pour bruxisme avec MC; 26.4 ± 2,8 / 14,6 ± 2.0mm Hg pour bruxisme avec éveil cortical et 
MC; 22,9 ± 5,2/12,4 ± 3,3mm Hg pour les épisodes de bruxisme seuls. 
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Conclusion: Le bruxisme du sommeil est associé à des hausses de la pression artérielle 
pendant le sommeil. Cette hausse est supérieure dans les épisodes de bruxisme associés à 
un éveil cortical et / ou MC, qui sont souvent associés avec les événements bruxisme. Ces 
résultats sont en accord avec nos observations antérieures, où le bruxisme est précédé par 
une augmentation de l'activité sympathique et de la tachycardie sinusale.  
 
Mots-clés : Sommeil, bruxisme, éveil cortical, mouvement du corps, ARMM 
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Abstract 
Objectives: Sleep Bruxism (SB) is a movement disorder identified by tooth grinding and 
rhythmic masticatory muscle activity (RMMA).  It is often associated with body 
movements and sleep arousals.   Increases in autonomic sympathetic activities that 
characterize sleep arousal precede SB.  These events include an augmentation of the 
following variables: sympathetic cardiac activity (-4 minutes), electroencephalography 
frequencies (-4 seconds), heart rate and respiratory amplitude (-1 seconds), and suprahyoid 
muscle activity (-0.8 seconds). This study examined whether these sympathetic activities 
are associated with significant changes in arterial blood pressure (BP). 
Methods:  Ten subjects with SB (5 male; 5 female; mean age ± standard error = 26 ± 1.8) 
underwent 3 nights of full polysomnography that included non-invasive beat to beat BP 
recording.  The first night served as a screening and habituation night.  Analysis was 
performed on second and third night recordings.  Overall analysis was based on single SB 
episodes occurring in stage 2 sleep only, for a total of 65 episodes. Systolic and diastolic 
BP measurements were taken from a window of 20 beats before and 23 beats after onset of 
each SB episode.  SB episodes were categorized as:  1) SB + cortical arousal; 2) SB + body 
movement (BM); 3) SB + cortical arousal + BM. A fourth category, SB alone, was also 
analysed but used as preliminary data since the category consisted of only 4 episodes. 
Results:  Both systolic and diastolic BP increased with SB episodes.  This increase was 
significant for both systolic and diastolic BP for SB events with cortical arousal and/or BM 
(p≤0.05).  The average BP surges (systolic/diastolic ± SE) were: 28.4 ± 2.4/13.2 ± 1.5mm 
Hg for SB + cortical arousal; 30.7 ± 1.6/19.4 ± 2.3mm Hg for SB + BM; 26.5 ± 2.8/14.6 ± 
2.0mm Hg for SB + cortical arousal + BM; 22.9 ± 5.2/12.4 ± 3.3mm Hg for SB episodes 
occurring alone. 
Conclusion:  Sleep bruxism is associated with blood pressure fluctuations during sleep.  
This BP surge is greater in SB episodes associated with cortical arousal and/or BM, which 
often co-occur with SB events.  These results are congruent with our previous observations, 
where SB is preceded by a rise in sympathetic activity and sinus tachycardia.  
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Keywords : sleep, sleep bruxism, blood pressure, cortical arousal, body movement, 
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Abbreviations 
ARMM Activité rhythmique des muscles masticateurs 
A.V.  Atrioventricular 
BM   Body movement 
BP  Blood pressure 
CAP  Cyclic alternating pattern 
DMH   Dorsomedial hypothalamic nucleus 
EEG  Electroencephalogram 
EMG  Electromyogram 
EOG  Electrooculogram 
GABA  Gamma-aminobutyric acid 
HF  High frequency 
LDT  Laterodorsal tegmental nuclei 
LF  Low frequency 
MC  Mouvement du corps 
MnPO  Median preoptic nucleus 
PLMS  Periodic leg movement during sleep  
PSG  Polysomnography 
PNS  Parasympathetic nervous system 
PPT   Pedunculopontine nuclei 
REM  Rapid eye movement 
RLS  Restless leg syndrome 
RMMA Rhythmic masticatory muscle activity 
RHT  Retinohypothalamic tract 
RSA  Respiratory sinus arrhythmia 
S.A.  Sinoatrial 
SB  Sleep bruxism 
SCN  Suprachiasmic nucleus 
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SDB  Sleep disordered breathing 
SE  Standard error 
SNS  Sympathetic nervous system 
SRRI  Serotonin reuptake inhibitors 
SWA  Slow wave activity 
SWS  Slow wave sleep 
VLPO  Ventrolateral preoptic nucleus 
 
  
  
ix
 
Table of Contents 
CHAPTER 1: INTRODUCTION ........................................................................................ 15 
1.1 SLEEP PHYSIOLOGY ............................................................................................. 16 
1.1.1 NREM and REM Sleep....................................................................................... 16 
1.1.2 Sleep Regulation and Consolidation ................................................................... 18 
1.1.3 Two Process Model of Sleep............................................................................... 18 
1.1.4 Sleep Mechanisms............................................................................................... 19 
1.1.5 Sleep/Wake Circadian Rhythm and Biological Clock ........................................ 22 
1.2 CARDIOVASCULAR FUNCTION DURING WAKE AND SLEEP...................... 23 
1.2.1 Cardiovascular Autonomic Regulation ............................................................... 23 
1.2.3 Cardiovascular Autonomic Regulation and Sleep .............................................. 26 
1.3 SLEEP BRUXISM..................................................................................................... 27 
1.3.1 Definition: ........................................................................................................... 27 
1.3.2 Epidemiology ...................................................................................................... 29 
1.3.3 Risk Factors and Consequences .......................................................................... 29 
1.3.4 Physiological Characteristics and Mechanisms .................................................. 30 
1.3.5 Diagnosis............................................................................................................. 33 
1.3.6 Management........................................................................................................ 34 
1.4 AROUSALS, PLMS, AND BP DURING SLEEP .................................................... 35 
1.4.1 Arousals: Cardiovascular Response from Sleep ................................................. 35 
1.4.2 PLMS and BP during Sleep ................................................................................ 35 
1.5 OBJECTIVES ............................................................................................................ 36 
1.6 HYPOTHESIS ........................................................................................................... 36 
CHAPTER 2: ....................................................................................................................... 37 
2.1 ABSTRACT............................................................................................................... 38 
2.2 INTRODUCTION ..................................................................................................... 39 
2.3 METHODS ................................................................................................................ 40 
2.3.1 Study Population ................................................................................................. 40 
  
x
 
2.3.2 Subject Recruitment ............................................................................................ 41 
2.3.3 Polysomnography................................................................................................ 42 
2.3.4 Data Collection ................................................................................................... 43 
2.3.5 SB Selection and SB Categories ......................................................................... 43 
2.3.6 Data Analysis ...................................................................................................... 44 
2.3.7 Statistical Analysis .............................................................................................. 45 
2.4 RESULTS .................................................................................................................. 45 
2.4.1 BP Changes with SB Episodes............................................................................ 46 
2.4.2 Differences in BP Increments between SB Categories ....................................... 47 
2.5 DISCUSSION ............................................................................................................ 48 
CHAPTER 3: DISCUSSION............................................................................................... 66 
CHAPTER 4: CONCLUSION............................................................................................. 72 
BIBLIOGRAPHY................................................................................................................ 73 
 
  
xi
 
List of Tables 
Table 1: Subject Demographics and Baseline BP during Wake...........................................53 
 
Table 2: PSG Summary with RMMA, PLSM, Cortical Arousal, and Respiratory Indices 
……………...........................................................................................................................54 
 
Table 3:  Distribution of Single SB Episodes Selected for each Subject..............................55  
 
Table 4:  Mean SDP and DBP Increases from Baseline for each SB Category, and Overall 
Group Effect…………………………...…………......................….....................................56 
 
Table 5: Start, Peak, and End of Significant BP Increase in Relation to SB Onset for Each 
SB Category………................................………………………..........................................57 
 
Table 6: Difference in BP Surges between the SB Categories:  Multilevel Analysis and 
Paired T Test Results…........................................................................................................58 
  
xii
 
List of Figures 
Figure 1:  Physiological Events Preceding SB.....................................................................33 
 
Figure 1.1: BP Increase associated with SB.........................................................................63 
 
Figure 1.2:  Changes in DBP in the four SB Categories.......................................................65 
 
Figure 1.3:  Changes in SBP in the four SB Categories........................................................66 
 
 
  
xiii
 
To my loving parents and family 
  
xiv
 
 
Acknowledgments 
I would first like to thank my director Dr. Gilles Lavigne, and co-director Dr. Paola 
Lanfranchi, for providing me with this research opportunity and for offering me so much 
support and encouragement throughout the process.  I have learnt so much from them both 
and feel very grateful to have had the chance to work under two supervisors who are so 
knowledgeable and passionate about their fields, and who are also so personable and 
humble.  
To the sleep laboratory team at Université de Montréal, I send my sincere gratitude.  
They made this research experience so positive and successful and I know I am very 
fortunate to have worked with such an exceptional group of people.  In particular, I would 
like to thank Christiane Manzini and Carmen Remo for their generous assistance and 
direction; Hajar El Alaoui for all her administrative and technical help; Pierre Rompré for 
his statistical contribution and his ability to make the statistical process surprisingly fun, as 
well as his ongoing interest and feedback in the project; Maria Clotilde Carra for being a 
super and always uplifting study mate and friend; Lorraine Fradette for making time to 
meet with me, at times outside of work, to help whenever I had any questions about the 
analysis and program; all the technicians and support staff at the sleep laboratory at Sacre 
Coeur Hopsital.  I would like to say a very special thank you to Nelly Huynh, aka ‘nelly 
boss’, who gave so much of herself to this project, and pushed me from beginning to end so 
that it could be completed in due time.  Her feedback, advice, and understanding were truly 
invaluable.   
Finally, I would like to thank my dear family: Dad, Mom, Joe and Mat, as well as 
my closest friends for giving me so much love and guidance.   
 
  CHAPTER 1: INTRODUCTION 
Sleep is an active state that occupies on average 1/3rd of a person’s lifetime. Despite 
the many theories surrounding its function its exact purpose is still not yet understood.  
There are two distinct stages that characterize sleep:  Rapid Eye Movement (REM) sleep 
and Non Rapid Eye Movement (NREM) sleep.  Variability within these stages allows for 
further classification, where NREM sleep is broken into stages 1, 2, 3 and 4.  Stages 1 and 
2 are known as ‘light sleep’, and stages 3 and 4 are referred to as deep, or slow wave sleep 
(SWS). REM sleep is divided into two phases: phasic and tonic REM.   These stages may 
be classified using standard methods of polysomnography (PSG) which involve: 
electroencephalogram on the scalp (EEG), electrooculogram (EOG) lateral to each eye, and 
electromyogram (EMG) on the chin.  Autonomic regulation including cardiovascular 
changes involving blood pressure (BP) and heart rate differ in sleep versus wakefulness and 
also between sleep stages.  
Involuntary movements are not uncommon during sleep and may be classified as a 
movement disorder type parasomnia depending on the severity.  Examples of such include 
teeth grinding, clinically known as sleep bruxism (SB), and restless leg syndrome (RLS).  
RLS, in particular, is often accompanied by periodic limb movements (PLMS) which are 
involuntary movements of the leg that have been shown to be accompanied by BP surges 
during sleep (1).  Few studies have examined whether SB causes similar effects, illustrating 
the aim of this study.  This review shall first describe sleep and its physiological 
mechanisms.  It shall then discuss the cardiovascular changes that occur during sleep, 
followed by a description of the pathophysiology of SB. It will conclude by addressing the 
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cardiovascular changes associated with PLMS and how similar manifestations are 
suspected to occur in SB.  
1.1 SLEEP PHYSIOLOGY 
1.1.1 NREM and REM Sleep 
A normal bout of sleep typically consists of 3 – 6 cycles of alternating NREM and 
REM periods.  These cycles, which are controlled by the ultradian process, range from 90 – 
120 minutes each (2). Upon sleep onset a decrease in EEG frequency activity, increase in 
EEG amplitude and a decrease in muscle activity are evident in normal sleepers (3).  
Further, the first sleep cycle usually begins in stage 1 and progresses throughout the NREM 
stages until REM sleep is initiated, usually occurring within 80 minutes after sleep onset 
(4). 
Stage 1 of NREM sleep serves mainly as a transitional stage between wake and 
sleep.  Usually only 1 – 7 minutes or 2-5% of total sleep time is spent in this stage (2).  It is 
characterized by theta waves (EEG range 5-9Hz) (5) and contains a low arousal threshold 
such that a person can be easily awakened when in this state (4).  Stage 2 sleep consumes 
approximately 10-25 minutes of a sleep cycle and is characterized by EEG sleep spindles 
and K complexes (6).  These are 2 types of EEG waves that carry a distinct morphology 
and frequency range.  K complexes in particular are high amplitude biphasic waveforms 
that occur either spontaneously or in relation to sensory stimuli and are often related to 
arousal (7).  Stage 2 sleep is deeper such that the type of stimuli that would normally 
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generate an arousal in stage 1 would result in a K complex in stage 2. Stage 2 sleep 
comprises approximately 45-55% of total sleep time (4).  Stages 3 and 4 (SWS) are 
comprised mainly of low frequency, high amplitude delta waves (EEG range 0.5-4.5Hz) 
that represent sleep intensity (8).  SWS comprise approximately 13-23% of sleep and its 
percentage and depth decrease significantly with age and this change has been shown to 
occur differently in men compared to women (4;9).  Further, the EEG power of slow wave 
activity (SWA) in SWS is an indicator of sleep depth (10).  Postural muscle tone is 
decreased during NREM sleep as a result of changes in action potential discharge (11).  
Heart rate, blood pressure and respiration are significantly reduced during NREM sleep 
(12).    Collectively, NREM stages are associated with sleep restoration.   
REM sleep differs from NREM on various levels.  First, it is most notably 
characterized by rapid eye movements, muscle hypotonia (during tonic phase), and an EEG 
that resembles wakefulness (desynchronized, low amplitude).  Due to the contrast between 
these latter two features the state is also known as ‘paradoxical sleep’.  REM sleep is 
associated with intense dreaming, cessation of thermoregulation, and irregular cardiac and 
respiratory activities leading to heart rate, BP, and respiratory instability (3).  These 
irregularities normally occur during the phasic events of REM sleep and are often 
accompanied by brief muscle twitches. Ponto-geniculo occipital (PGO) spikes, which are 
forms of electrical potentials specific to REM sleep, are also signature features of this state 
and are linked to rapid eye movements.  The exact physiological and psychological purpose 
for REM sleep, relating to health, is unknown.  
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1.1.2 Sleep Regulation and Consolidation 
Current literature supports the hypothesis that sleep consolidation is achieved via 
three integrated processes: i) Process S, which represents homeostasis of sleep regulation; 
ii) Process C, which represents the circadian rhythm process; iii) Ultradian process, which 
involves NREM and REM cycles during sleep.  Process S is described as the homeostatic 
drive for sleep where during wakefulness the physiologic ‘need for sleep’ builds up in the 
body and diminishes during sleep recovery.  This homeostatic sleep drive is represented by 
NREM sleep such that following sleep deprivation enhanced NREM SWS is observed 
rather than significant increases in sleep duration (13).  Process C describes the circadian 
component of sleep regulation.  The circadian rhythm in mammals is a biological rhythm 
that runs on a 24hr cycle except under ‘free running’ conditions, (i.e. when external 
environmental cues are absent from the cycle). Its physiology will be discussed more in 
further sections.   
1.1.3 Two Process Model of Sleep 
Although the length of a single NREM/REM sleep cycle remains relatively constant 
throughout sleep duration their relative proportions shift with each cycle.  Specifically, the 
first 2/3rds of sleep consist more of NREM than REM sleep and this proportion decreases 
with progressing cycles.  Conversely, the proportion of REM sleep increases in length with 
each consecutive cycle, and thus dominates the final 1/3 part of sleep. According to the two 
process model of sleep regulation a homeostatic sleep pressure exists that corresponds to a 
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‘sleep drive’ that accumulates during wakefulness.  This pressure decreases upon sleep 
onset since the need for sleep is being met, and is believed to be represented by NREM 
sleep; more specifically the power of EEG (SWA).  This notion is supported by the NREM 
cycle pattern, which shows that NREM and specifically SWA are long and more intense 
during the first few sleep cycles, due to the high homeostatic sleep drive accumulated 
during wakefulness, and decreases with ongoing sleep in conjunction with the reducing 
homeostatic sleep pressure.  Simultaneously, the circadian sleep drive rises during later 
sleep cycles to compensate for this decreased homeostatic sleep pressure, allowing for sleep 
consolidation and prevention of early awakenings.  Thus, it is the integrated activities 
between the homeostatic and circadian sleep drive that allow sleep to be sustained for a full 
7-9 hours (13;14).  
1.1.4 Sleep Mechanisms 
i) Wake 
Wakefulness is actively maintained via the ascending reticular activating system in 
the brain.  It is mainly achieved via two pathways: i) the dorsal pathway, which travels 
through the thalamus and involves cholinergic cells found in the pedunculopontine and 
laterodorsal tegmental nuclei (PPT/LDT); ii) the ventral pathway, which passes through the 
hypothalamus and basal forebrain and consists of monoaminergic cells originating in the 
following areas: noradrenergic locus coeruleus, serotoninergic dorsal raphe nucleus, 
dopaminergic ventral peraqueductal grey matter, and histaminergic tuberomammillary 
nucleus (15-17).  Cholinergic neurons exist in the basal forebrain which contributes 
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significantly to arousal. Further, there are selective neurons in the reticular formation that 
release glutamate and contribute to cortical activation as well (18-21). 
The neurons in the monoaminergic system are known as ‘REM off’ cells in 
reference to their absence of firing during REM sleep compared to during wakefulness and 
other sleep states (22;23). In contrast, neurons of the cholinergic system show robust 
activity in both wake and REM states and are therefore referred to as ‘Wake on/REM on’ 
cells (24).  In addition, there are a group of cells in the lateral hypothalamus which contain 
orexin/hypocretic neurons that are essential for reinforcing monoaminergic arousal activity 
and play a critical role in stabilizing wakefulness. These neurons are discussed further in 
following sections (25;26).  The cortical activity generates EEG that consists of high 
frequency, low amplitude, desynchronized beta waves, (range 14-30Hz) (27). 
ii) Sleep Onset  
Sleep is initiated actively via inhibition of the arousal systems.  The main source of 
this inhibition comes from the ventrolateral preoptic nucleus (VLPO) region, which release 
GABA and Galanin, and the median preoptic nucleus (MnPO), which releases GABA to 
these regions (28-31).  The VLPO neurons are ‘warm-sensitive’ and release their inhibitory 
signals in response to increased temperature in this region (32).  The core VLPO acts 
primarily on the histaminergic tuberomammillary nucleus, which influences transitions 
between arousal and NREM sleep (33-35).  The extended VLPO acts primarily on the locus 
coeruleus and the dorsal and median raphe nuclei which influences REM sleep initiation 
(33).  Collectively, these neurons are referred to as ‘NREM on’ cells and their activities are 
linked to homeostatic sleep regulation (36). 
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iii) The ‘Flip Flop Switch’ 
When the VLPO neurons fire during sleep they send inhibitory signals to the 
monoaminergic arousal system that depress arousal (37-39).  Similarly, when the 
monoaminergic neurons are active during wakefulness they are sending inhibitory signals 
to the VLPO region.  Specifically for wakefulness, noradrenaline and serotonin released 
from the monoaminergic pathway and GABA released from the tubermammillary nucleus, 
inhibit VLPO neurons and prevent them from initiating sleep (40-42).  Therefore, it is 
apparent that both wake and sleep states are self reinforcing such that when one system is 
active it sends inhibitory signals to the opposing system.  In other words, the mechanism 
that controls sleep and wakefulness is a mutual inhibitory system known as a ‘flip flop 
switch’.   It acts to limit transitional states between wakefulness and sleep and ensure 
stability within each state (43).   
Orexin/hypocrein neurons in the lateral hypothalamus play a major role in this 
system (25;26;44;45). These neurons contain major projections to the regions of the 
monoaminergic arousal pathway such that, when absent, the ability to sustain wakefulness 
is severely disrupted causing frequent switching between arousal and sleep, which is 
commonly seen in individuals with narcolepsy (26;46-48).  In addition, when neurons in 
the VLPO region are damaged the ability to consolidate long bouts of sleep is interrupted, 
leading to severe sleep fragmentation (49).  Thus, if one side of the sleep/wake switch is 
severed, a decrease in overall sleep/wake stability is produced (43). 
iv)  REM Mechanism  
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REM is initiated by ‘REM on’ cells that originate in the pons and the medial 
medulla of the brain (50).  These cells involve the neurotransmitters: acetylcholine, 
glutamate, glycine, and GABA (51;52). They promote REM behaviour as well as inhibit 
‘REM off’ cells, which consist of the noradrenergic, serotonergic, and histaminergic cells, 
as previously mentioned (53-56).  When these ‘REM off’ cells are inhibited by GABA their 
inhibition promotes further GABA release, reinforcing the REM state (57-60).  The 
characteristic hypotonia of REM sleep is generated by the release of GABA and glycine by 
the medulla, as triggered by the pons’ via acetylcholine and glutamate (51;52).   
1.1.5 Sleep/Wake Circadian Rhythm and Biological Clock 
All mammalian cells follow a circadian rhythm.  The ‘master biological clock’ that 
regulates the circadian rhythm of most cells and behaviours is the suprachiasmic nucleus 
(SCN) (61;62).   It is situated in the anterior hypothalamus of the brain (63) and its 
regulation includes that of the sleep-wake cycle, implying its role in sleep regulation (64).  
Anatomically, the SCN receives light cues via the retinohypothalamic tract (RHT) which 
allows external daylight to entrain the circadian rhythm to 24hrs (65;66).  The SCN 
connects densely to the subparaventricular zone (SPZ) where the dorsal aspect is suggested 
to regulate circadian rhythm of body temperature (67). The ventral aspect, in contrast, is 
densely connected to the dorsomedial hypothalamic nucleus (DMH).  It is this region that 
contains major glutaminergic projections to the orexin/hypocretin lateral hypothalamus and 
GABAergic VLPO area, demonstrating the anatomical link between the SCN and 
sleep/wake regulation (67;68). 
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1.2 CARDIOVASCULAR FUNCTION DURING WAKE AND 
SLEEP 
1.2.1 Cardiovascular Autonomic Regulation  
Autonomic regulation of the cardiovascular system is realized by the 
parasympathetic and sympathetic nervous systems. Both systems are centrally controlled by 
the medulla oblongata but are also significantly influenced by the hypothalamus and cortex.  
The parasympathetic nervous system’s (PNS) influence predominates in resting conditions, 
largely effecting resting heart rate and cardiac contractility.  It exerts its effects via the 
vagus nerve by the release of acetylcholine.  The sympathetic nervous system (SNS), in 
contrast, exerts a cardioacceleratory effect on the heart and causes vasoconstriction of the 
blood vessels and increased cardiac contractility via norepinephrine release. BP regulation 
is achieved via baroreceptors and chemoreceptors, which provide immediate responses to 
changes in BP and blood chemistry.  As well, the renin-angiotensin-aldosterone system and 
vasopressin contribute to long term regulation of BP.  The aim of this entire system is to 
ensure that oxygen demands are sufficiently being met via cardiovascular mechanisms (69).   
Parasympathetic and Sympathetic Activity 
The PNS center is located in the dorsal motor nucleus and nucleus ambiguous 
region of the medulla.  It is fast acting (0-0.5Hz) where pharmacological and surgical 
studies have shown that it is responsible for the high frequency (HF) component in spectral 
analysis of heart rate variability. Furthermore, this HF component is associated with the 
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respiratory rhythm and respiratory sinus arrhythmia (RSA). PNS activity functions 
cholinergically via acetylcholine release onto nicotinic and muscarinic receptors. It is 
regulated by the nucleus tractus solitarius in the hindbrain (70;71).  The vagus nerve, which 
arises from this region, consists of a right and left component that innervate the sinoatrial 
(S.A) and atrioventricular (A.V) node of the heart, respectively.  These are the only two 
direct innervations the PNS has to the heart and it induces a bradycardiac effect.  At resting 
conditions the PNS is the main contributor to heart rate regulation.  Blood vessels do not 
have direct parasympathetic innervations (72).    
The sympathetic center is located in the rostral ventrolateral medulla and its activity 
is regulated by the medullary reticular formation, the same area involved in wake and 
arousal activation (73). The SNS response is slower than the PNS (0.1Hz), thus  under 
spectral analysis it mainly contributes to the low frequency (LF) components of heart rate 
and BP oscillations (74). The system functions via the release of norepinephrine from 
sympathetic postganglionic neurons, and epinephrine from the adrenal medulla.  
Norepinephrine and epinephrine bind to two types of adrenergic receptors: alpha and beta.  
Alpha receptors induce vasoconstriction. Alpha1 receptors in particular contribute to 
increased cardiac contractility. Beta1 receptors located on the myocardium induce positive 
inotropic and chronotropic effects.  The sympathetic innervations specific to the heart are 
generated from the stellate ganglion. Unlike the PNS, these sympathetic fibres are not 
limited to the S.A and A.V node but have connections to all areas of the heart (75).  Beta2 
receptors are located on blood vessels and veins found vastly on the heart and skeletal 
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muscle and induce vasodilation and bronchodilation.  Furthermore, since epinephrine has a 
greater affinity towards beta receptors it generally induces vasodilation along with 
increased cardiac outputs at low secretions (76).   
Blood Pressure Regulation 
BP is the measure of blood flow force against the blood vessel wall. It is a product 
of cardiac output and total peripheral resistance, where cardiac output is defined as the total 
blood volume pumped by the heart ventricles each minute.  Specifically, BP consists of two 
measures: systolic and diastolic, where the former is the peak arterial pressure during 
ventricular contraction and the latter is the lowest arterial pressure during ventricle 
relaxation.  In normal healthy individuals the average systolic/diastolic pressures are 
120mmHg/80mmHg.  BP regulation is vital to ensure that blood is sufficiently being 
transported to tissues, and that BP measures do not escalate too high as this can cause 
vascular and cardiac tissue damage.  BP regulation involves short and long term 
mechanisms.  Only short term BP regulation will be described, namely the baroreceptor and 
chemoreceptor functions (77). 
Baroreceptors are stretch receptors that function mechanically in response to 
changes in BP.  Those located in the carotid sinus and the aortic arch contribute the greatest 
information.  Afferent signals received from these sensors are sent to the nucleus tractus 
solitarius through the vagal nerve, altering sympathetic output.  Baroreceptor function is 
achieved as follows: an increase in arterial pressure is detected mechanically by the stretch 
receptors in the arteries which initiate an increase in PNS response and a decrease in SNS 
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firing.  This elicits bradycardia and blood vessel vasodilation. In contrast, a reduction of 
pressure on the baroreceptors stimulates SNS activity and reduces PNS function stimulating 
vasoconstriction, tachycardia, and increases in cardiac contractility (72). 
Chemoreceptors are also involved in blood pressure regulation during hypoxia and 
hypercapnia, which may occur, for instance, in sleep apnea. Chemoreceptors can be found 
centrally in the medulla, and peripherally in the carotid and aortic bodies.  Both regions 
monitor carbon dioxide however the peripheral receptors also respond to hypoxia.  
Autonomic changes elicited by central chemoreceptor activation include sympathetic 
excitation leading to vasoconstriction and increased arterial BP (76). Stimulation of 
peripheral chemoreceptor by profound hypoxia may induce simultaneous parasympathetic 
cardiac activation leading to significant lowering of heart rate (78). 
1.2.3 Cardiovascular Autonomic Regulation and Sleep 
In general, BP and heart rate during sleep decrease by approximately 10% compared 
to wake (79).  Particularly for BP, these decreases are referred to as ‘dipping’ and result 
from an active decrease in the baroreflex set point (80).  It has been shown that PNS and 
heart rate are regulated by the circadian rhythms, and PNS activity increases in anticipation 
of sleep onset.  SNS activity and its corresponding influences on BP regulation, rather, are 
sleep/wake driven such that in 24h sleep deprived subjects who remain in the supine 
position show a decrease in HR but not BP (81;82).  In addition, cardiac changes have been 
shown to precede EEG changes during sleep, possibly in anticipation of sleep stage 
transitions (83). 
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NREM and REM 
Autonomic control differs significantly between NREM and REM sleep.  NREM 
sleep is characterized by autonomic stability where BP, heart rate, and cardiac output are all 
decreased (84).  The state is dominated by vagal nerve activity which is progressive from 
stages 1 to 4.  Sympathetic activity is decreased in NREM sleep by approximately 50% 
from wakefulness causing BP to reach nadir values in stage 4 of this state (85;86). In 
addition, baroreflex sensitivity is increased in response to BP increments (87).  These 
mechanisms serve to maintain normal arterial BP during NREM sleep.   
In contrast, REM sleep is a state of unstable autonomic activity dominated by 
fluctuations between parasympathetic and sympathetic activity.  These fluctuations 
contribute to irregular heart rate, BP, and breathing activity (88-90).  Specifically, phasic 
REM is associated with increased heart rate and BP surges due to increased cardiac 
sympathetic activity, that are attenuated suddenly due to baroreceptor reflex activity (89;91-
93).  Tonic REM, on the other hand, is associated with abrupt decelerations in heart rate 
that are independent of respiratory and baroreflex influences. Data suggest that this might 
be due to increased vagal activity (94). 
1.3 SLEEP BRUXISM 
1.3.1 Definition: 
Sleep bruxism is classified as a parasomnia, a movement disorder during sleep 
characterized by tooth grinding and/or clenching, and rhythmic masticatory muscle activity 
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(RMMA) (95).  RMMA is the measure used to diagnose SB, however for the purpose of 
this thesis the terms SB and RMMA will be used interchangeably to describe teeth grinding 
episodes.  SB should be distinguished from daytime clenching since the proposed causes 
are suspected to differ.  SB may present itself idiopathically or can occur secondary to an 
existing condition (iatrogenic bruxism) which can result from either a different movement 
disorder (ie. PLMS, Parkinson’s disease etc.), or from drug intake/withdrawal (ie. 
neuroleptics inducing teeth grinding) (96).   
SB episodes may manifest as either single or cluster episodes.  A single SB episode 
is defined as an event that is isolated from additional SB events occurring within 60 
seconds of the given SB episode.  Cluster SB episodes rather, consist of multiple SB events 
that occur within 20 – 30 seconds of each other (97).  An SB burst is defined as a 
masticatory muscle movement where the EMG amplitude reaches at least 10% of 
maximum voluntary contraction of awake subjects.  SB episodes are scored as phasic, 
tonic, and mixed.  A phasic episode consists of three SB bursts or more where each burst 
lasts 0.25 to 2.0 seconds.  The majority of SB episodes occur in this phasic form which 
represent the RMMA that is characteristic of SB.  A tonic episode is an SB burst lasting 
more than 2.0 seconds.  A mixed episode consists of both of these types of episodes that 
occur within an interval of 3.0 seconds (98).  SB episodes can occur with or without tooth 
grinding noise.  Its diagnosis is based on at least four SB episodes per hour (if episodes are 
occurring without noise), or a minimum of 25 SB bursts per hour of sleep, or at least one 
SB episode that occurs with noise per sleep period (98).  SB diagnosis is represented by an 
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RMMA index indicating the number of SB episodes per hour of sleep (99). SB may be 
classified as mild to moderate (2 ≤ RMMA index ≤ 4), or severe (RMMA index > 4).   
1.3.2 Epidemiology 
SB, or more precisely, the awareness of tooth grinding as reported by a sleep 
partner, is present in 8% of the adult population.  It is more common in children and young 
adults (13%) and is shown to decrease with age (3% in the elderly) (100).  Of relevance, 
these SB prevalence figures are most often generated from self report data that are usually 
based on daytime clenching (present in 20% of the population) (101).  Clenching, however, 
does not always correspond to an SB diagnosis. Further, many individuals who have SB are 
not aware of their condition because they either sleep alone or have a ‘deep sleep’ sleep 
partner (96)  
1.3.3 Risk Factors and Consequences 
Various risk factors have been suggested to contribute to the etiology of SB.  
Psychological factors such as stress and anxiety with Type – A personality have been 
linked to its causes (102) albeit controversially (103;104).  SB has been reported to co-
occur often in patients with sleep apnea, and is present in 10% of patients with RLS (105).  
As well, smoking, alcohol, and caffeine have all been shown to exacerbate this condition 
(106;107).  Consequences of SB include tooth wear, temporomandibular joint and muscle 
pain, as well as headaches (in both adults and children) (108). Interestingly, orofacial pain 
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is experienced significantly more in individuals who have mild to moderate rather than 
severe SB (109). 
1.3.4 Physiological Characteristics and Mechanisms 
In general young and healthy sleep bruxers are good sleepers with normal overall 
sleep macrostructure, including normal sleep stage distribution and arousal indices when 
compared to controls.  The majority of SB events occur during NREM sleep (110-112), 
most often right before transitions into REM (112).  Although the etiology of SB remains 
unknown the physiological mechanisms preceding or associated with SB/RMMA activity 
are well documented in the literature. It has been shown that subjects with SB have an 
overall elevated sympathetic tone during wake (113). SB episodes are associated with both 
body movement and cortical arousal (111;112;114;115;115).  More specifically, the vast 
proportion of SB episodes (87.3%) have been shown to occur in phase A of the cyclic 
alternating pattern (CAP) (111). CAP is an index of sleep instability consisting of phase A 
and phase B where phase A is associated with heightened EEG, muscle, and autonomic 
activity (116-118).  
In conjunction with SB’s temporal association with cortical arousal the 
physiological mechanisms preceding SB are also arousal related.  Arousals are normally 
characterized by tachycardia followed by bradycardia and can occur with or without EEG 
desynchronization (cortical or subcortical arousal) (119).  These events are similar to the 
physiological sequences involved in SB which consist of the following activities: an 
increase in sympathetic activity before SB onset (-4 to -8 minutes) (112), followed by an 
  
31
 
increase in EEG activity (cortical arousal) (-4 seconds); tachycardia occurs 1 second before 
SB (111;115), followed by an increase in respiratory amplitude concomitant with SB onset 
(120).  These sequences of events can be viewed in Figure 1. 
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Figure 1. Physiological Events Preceding SB 
 
Figure 1. Sequence of events preceding SB: increases in sympathetic activity (-4 to -8 minutes); increase in 
EEG activity (cortical arousal) (-4 seconds); tachycardia occurs (-1 second); an increase in respiratory 
amplitude (simultaneous to SB onset.)  
The dotted vertical line indicates SB onset. 
Modified from Lavigne et. al. Principles and Practice of Sleep Medicine, Krygor MH, et. al. Elsevier 2005. 
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1.3.5 Diagnosis  
Bruxism diagnosis is clinically based on a patient’s history and orofacial 
examination that involves the analysis of tooth wear, masseter muscle hypertrophy, as well 
as the presence of jaw discomfort, pain, and temporomandibular joint disorder.   
SB is more accurately diagnosed when using PSG as a diagnostic tool since it 
allows SB to be distinguished from other orofacial movements (121).  PSG for SB 
diagnosis requires the following electrodes: 2 EEG (C3 -A2, O2 - A1), right and left EOG, 
EMG of the masseter and temporalis, for SB scoring; chin and suprahyoid, to observe 
hypotonia during REM sleep; and anterior tibialis, to rule out PLMS. Nasal air flow, 
respiratory effort measures using abdominal and chest belts, and the use of a microphone to 
monitor sleep apnea, snoring, and tooth grinding are also mandatory requirements for PSG 
SB diagnosis.  In addition, video recordings are included to allow for differentiation 
between orofacial movements and actual SB/RMMA.  Biocalibrations are performed where 
actions such as swallowing, teeth tapping, and clenching are executed voluntarily to test 
EMG recordings and assist with SB scoring for each patient.  All PSG data should be 
recorded with a computer at a minimum acquisition speed of 128Hz, with computer screen 
epochs set at 20-30 seconds (96;98).  For each event the SB scorer should specify if the SB 
occurred with tooth grinding sounds, or silently.  
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1.3.6 Management 
Since no cure exists for SB, only treatment options are available to assist with its 
management.  Specifically, the main goal of the clinician is to manage tooth wear and jaw 
joint pain.  Such treatments include behavioural treatment, occlusal appliances, and 
pharmacological management.  Behavioural treatments normally focus on changes in sleep 
hygiene as well as stress and relaxation management.  The effects on SB have not been 
significant but many report improved well being (122;123).  Occlusal appliances include 
devices such as mouth guards or stabilization bite splints, where the latter have been proven 
to be particularly effective at preventing tooth wear (124).  Special attention should be 
made when prescribing these appliances, however, since they have the potential to 
exacerbate sleep disordered breathing (SDB) if patients present both SB and SDB (125).  
Furthermore, compliance is always a concern.  A device called the mandibular 
advancement device is also available which functions by moving the jaw forward. It has 
been shown to treat sleep apnea and SB (126-128).  Lastly, pharmacological options such 
as benzodiazepines and muscle relaxers can also be used for short term management of SB 
(129-131).  Selective alpha2 adrenergic agonists (clonidine) have been shown to reduce SB, 
although this treatment is not recommended in clinic due to the side effect of severe 
morning hypotension (132).  The antidepressant medication selective serotonin reuptake 
inhibitors (SSRI’s) have been shown to actually induce clenching and tooth grinding (133). 
.     
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1.4 AROUSALS, PLMS, AND BP DURING SLEEP 
1.4.1 Arousals: Cardiovascular Response from Sleep  
Arousal from sleep is associated with transient increases in both BP and heart rate, 
as a reflection of increased sympathetic activity, and are often followed by bradycardia 
most likely due to the baroreflex system (134).  There is evidence that the rise in heart rate 
is associated with increases in both slow (delta) and fast (theta) EEG activity (135). These 
heart rate changes have been shown to occur in both cortical and sub cortical arousals.  In 
addition, there is evidence for a sleep stage effect on the magnitude of the BP surge since 
arousal related surges during REM sleep have been shown to be smaller than those 
occurring in NREM sleep (134). 
1.4.2 PLMS and BP during Sleep  
 PLMS is a sleep movement parasomnia, like SB, and both disorders share similar 
physiological patterns.  PLMS, for example, are associated with arousal and display a 
tachycardiac/bradycardiac pattern (136).   Further, the majority of PLMS events have been 
shown to occur during Phase A of the CAP sequence (137).  It has been demonstrated that 
PLMS, whether or not associated with EEG arousal, are associated with increases in BP 
(1;134).  The physiological similarities between SB and PLMS raise the question as to 
whether SB events are also associated with BP surges. 
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1.5 OBJECTIVES  
The aim of this study is to determine if a significant increase in BP is associated with SB. 
This objective is based on the current knowledge of SB, particularly that it is preceded by 
sympathetic activities including tachycardia, increased respiratory amplitude, and cortical 
arousal.  Since SB is associated with cortical arousals and body movements the study will 
also examine whether these events influence the suspected SB related BP surge.  This study 
will focus on pure, single SB episodes occurring in stage 2 sleep only, where the majority 
of SB episodes take place. 
1.6 HYPOTHESIS 
The hypotheses are the following:  
1. SB is associated with BP changes that involve an increase in both systolic and 
diastolic blood pressure (SBP and DBP). 
2.  BP changes will vary depending on whether SB events occur alone, or are 
associated with arousals and/or body movements.  Specifically, we will be 
examining SB episodes in four categories:  1) SB + cortical arousal; 2) SB + body 
movement; 3) SB + cortical arousal + body movement 4) SB alone.  
 CHAPTER 2:  
 
Sleep Bruxism is Associated with a Rise in Blood Pressure 
 
Nashed, A., Lanfranchi, P.A., Carra, M., Rompré, P., Mayer, P., Huynh, N.,  Lavigne, G. 
(to be submitted to a sleep related journal) 
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2.1 ABSTRACT 
Objectives: Sleep Bruxism (SB) is a movement disorder identified by tooth grinding and 
rhythmic masticatory muscle activity (RMMA).  It is often associated with body 
movements and sleep arousals.   Increases in autonomic sympathetic activities that 
characterize sleep arousal precede SB.  These events include an augmentation of the 
following variables: sympathetic cardiac activity (-4 minutes), electroencephalography 
frequencies (-4 seconds), heart rate and respiratory amplitude (-1 second), and suprahyoid 
muscle activity (-0.8 second). This study examined whether these sympathetic activities are 
associated with significant changes in arterial blood pressure (BP). 
Methods:  Ten subjects with SB (5 male; 5 female; mean age = 26 ± 1.8) underwent 3 
nights of full polysomnography that included non-invasive beat to beat BP recording.  The 
first night served as a screening and habituation night.  Analysis was performed on second 
and third night recordings.  Overall analysis was based on single SB episodes occurring in 
stage 2 sleep only, for a total of 65 episodes. Systolic and diastolic BP measurements were 
taken from a window of 20 beats before and 23 beats after onset of each SB episode.  SB 
episodes were categorized as:  1) SB +cortical arousal; 2) SB + body movement (BM); 3) 
SB + cortical arousal + BM. A fourth category, SB alone, was also analysed but used as 
preliminary since the category consisted of only 4 episodes. 
Results:  Both systolic and diastolic BP increased with SB episodes.  This increase was 
significant for both systolic and diastolic BP for SB events with cortical arousal and/or BM 
(p≤0.05).  The average BP surges (systolic/diastolic ± SE) were: 28.4 ± 2.4/13.2 ± 1.5mm 
Hg for SB + cortical arousal; 30.7 ± 1.6/19.4 ± 2.3mm Hg for SB + BM; 26.4 ± 2.8/14.6 ± 
2.0mm Hg for SB + cortical arousals + BM; 22.9 ± 5.2/12.4 ± 3.3mm Hg for SB alone. 
Conclusion:  Sleep bruxism is associated with blood pressure fluctuations during sleep.  
This BP surge is greater in SB episodes associated with cortical arousal and/or BM which 
often co-occur with SB events.  These results are congruent with our previous observations, 
where SB is preceded by a rise in sympathetic activity and tachycardia.  
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2.2 INTRODUCTION 
Sleep Bruxism (SB) is a movement disorder identified by tooth grinding and 
rhythmic masticatory muscle activity (RMMA). Subjects with SB are generally good 
sleepers with normal overall sleep macrostructure including normal sleep stage distribution 
and arousal indices when compared to controls.  The majority of SB events occur during 
NREM sleep (110-112), most often right before transitions into REM (112).  Although the 
etiology of SB remains unknown the physiological mechanisms preceding or associated 
with SB activity are well documented in the literature.  It has been shown that subjects with 
SB have an overall elevated sympathetic tone during wake (113). SB episodes are 
associated with both body movement and sleep arousal (111;112;114;115).  More 
specifically, the vast proportion of SB have been shown to occur in phase A of the cyclic 
alternating pattern (CAP) (87.3%) (111).  CAP is an EEG arousal pattern consisting of 
phase A and phase B, where phase A is associated with the strongest arousal pressure 
linked with heightened EEG, muscle, and autonomic activity (116-118). 
In conjunction with SB’s temporal association with cortical arousal the 
physiological mechanisms preceding SB are also arousal related.  Specifically, arousals are 
normally characterized by tachycardia, often followed by bradycardia (119), and can occur 
with or without EEG desynchronization (cortical or subcortical arousal).  These events are 
similar to the physiological sequences involved in SB which consist of the following 
activities: an increase in sympathetic activity before SB onset (-4 to -8 minutes) (112), 
followed  by an increase in EEG activity (cortical arousal) (-4 seconds); tachycardia occurs 
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1 second before SB (111;115), followed by an increase in respiratory amplitude 
concomitant with SB onset (120).   
These physiological sequences observed in SB have also been described in other 
sleep movement disorders.  Periodic leg movements during sleep (PLMS), for example, are 
also associated with arousal and display a tachycardiac/bradycardiac pattern (136).    Both 
PLMS and cortical arousal are associated with increases in blood pressure (BP) where 
PLMS was shown to exhibit a higher BP surge when co-occurring with arousal (1;134).   
The aim of this study was to determine if SB also exhibits a significant increase in 
BP in subjects with SB, and to identify if this fluctuation varies in the presence of cortical 
arousals and/or body movements.  Given the current knowledge on the physiological 
sequences associated with SB genesis, particularly the preceding arousals and increases in 
sympathetic activities, we hypothesize that SB is associated with BP changes; more 
precisely with increases in both systolic and diastolic blood pressures (SBP and DBP).  We 
also predict that these changes will vary depending on whether the SB events occur alone, 
or in association with arousals and/or body movements.   
2.3 METHODS 
2.3.1 Study Population 
The study consisted of 10 subjects (5 male; 5 female; mean age ± standard error = 
26 ± 1.8 years) who reported a history of SB.  Inclusion criteria required that subjects be 
between 18 and 45 years of age and report a history of SB occurring at least three times per 
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week.  Subjects were included if they had at least mild to moderate SB (RMMA index ≥ 
2.0), as confirmed by polysomnography (PSG) (138).  Subjects were excluded if they had 
medical or psychiatric co-morbidity, or additional sleep disorders such as sleep apnea, 
insomnia, or RLS, as well any severe dental occlusion problems.  A summary of subject 
characteristics are reported in Table 1.   
2.3.2 Subject Recruitment 
Subject recruitment involved three stages.  The first stage consisted of a screening 
via telephone questionnaire.  If subjects reported frequent morning jaw discomfort and had 
dental reported tooth wear, or if a sleep partner had complained of their tooth grinding, the 
subjects were invited to the laboratory for a second stage of clinical assessment.  This 
assessment involved: i) additional questionnaires which examined general health, SB, SB 
and pain, headaches, daytime sleepiness, and sleep quality; ii) a clinical examination for SB 
by our dentist including a physical assessment of the jaw, neck, and mouth; iii) a dental X-
Ray to examine dental health and assess the temperormandibular joint (TMJ).  If subjects 
met clinical screening criteria they were scheduled for a single sleep study at the sleep 
laboratory at l’Hôpital du Sacré Coeur de Montréal which was the final stage of the SB 
assessment.  This sleep study was used to confirm diagnosis and rule out any additional 
sleep disorders.  If accepted, subjects were asked to return for an additional two sleep 
studies. 
The protocol was approved by the institutional ethics committee.  All participants of 
the study read and signed a written consent form describing the study procedure in detail 
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with the information that they were free to withdraw at any time.  A reimbursement of 75$ 
was given to each subject per sleep night. 
2.3.3 Polysomnography 
Sleep studies involved full night polysomnography (PSG) (at least 7 hours) 
consisting of standard methods that included the following recordings:  
electroencephalogram (EEG) leads (C3 – A2 and O2 - A1), two bilateral electrooculograms 
(EOG), and electromyograms (EMG) on the chin, the tibialis muscle, the suprahyoid 
muscle, and the bilateral masseters and temporalis muscles.   Further, cardiovascular 
signals were provided by a 3-lead electrocardiogram (ECG) and non-invasive beat-to-beat 
blood pressure (TNO-BMI, Academic Medical Centre, Amsterdam, the Netherlands) as 
detailed below.  Signals were recorded at a sampling rate of 256Hz using Harmonie 
Software; Stellate Systems; Montreal, QC, Canada.  Respiratory assessments were made 
using a nasal cannula (Braebon Medical Corporation; Kanata, ON, Canada), thoracic and 
abdominal belts, plus a finger pulse oximeter (Datex-Ohmeda; Louisville, CO). Audio and 
video recordings were also included for all PSG.  Subjects were free of any medications 
(excluding oral contraceptives), and were asked to avoid day time naps, caffeine, and 
alcohol on the day of PSG recordings.   
All studies were scored by a sleep technician according to Rechtschaffen and Kales 
sleep stage scoring criteria (139).  SB was scored according to standard research criteria 
(140;141).  Specifically, a phasic SB episode was scored when an SB episode consisted of 
at least 3 SB bursts, as measured by masseter muscle EMG, lasting 0.25 to 2.0 seconds 
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each, with an interval of two interburst pauses.  A tonic SB episode was scored when a SB 
burst lasted longer than 2.0 seconds. SB diagnosis is represented by an RMMA index 
indicating the number of SB episodes per hour.  Both audio and video were used to 
correctly distinguish orofacial movements from actual SB/RMMA, as well as document 
any body movements that co-occurred with SB (141-143).  Sleep disordered breathing 
events, cortical arousals, and PLMS were all scored according to American Academy of 
Sleep Medicine criteria (144).    
2.3.4 Data Collection  
Baseline wake arterial BP measures were taken using a brachial cuff in the evening 
before subjects were prepared for PSG set up.  This BP measurement was obtained while 
subjects were in the seated position after five minutes of rest.  All subjects had normal SBP 
and DBP measures which can be viewed on Table 1. 
Nocturnal beat-to-beat measures of BP were obtained with the Portapres using 
finger cuffs. This method has been validated to accurately measure BP fluctuations when 
compared to an invasive intra – brachial BP recording device (145;146).  This device was 
previously used in our laboratory to monitor beat to beat blood pressure recordings in 
subjects with insomnia and RLS (147;148).   
2.3.5 SB Selection and SB Categories 
Only single SB episodes were selected for examination in this study.  A single SB 
episode was defined as an SB event that was absent of additional SB episodes in the 60 
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seconds preceding, and 30 seconds following a given event. These criteria were used to 
avoid confounding the BP baseline with cluster SB episodes. In addition, since our lab has 
found that the majority of SB episodes occur in stage 2 sleep, only events in this stage were 
analysed to avoid sleep stage effect on BP (97).   
All SB events were categorized based on their associated events: i) SB + arousal; ii) 
SB + body movement; iii) SB + arousal + body movement; iv) SB alone, where arousals 
refer specifically to cortical arousals.  SB episodes with arousal and/or body movement 
were selected only if the arousals and/or body movements began within the 5 seconds 
preceding SB to ensure that BP changes were SB related.  Stable BP before each SB 
episode was ensured for all episodes selected for analysis.  Furthermore, SB events that 
coincided with any additional physiological events, such as sleep apneas/hypopneas events, 
upper airway resistance events, or technical limitations (i.e. signal artefact) that could have 
confounded the BP changes were omitted from analysis.  
2.3.6 Data Analysis 
BP measurements were taken across a temporal window of 43 seconds: 20 beats 
before, 6 beats during, and 15 beats after SB onset of single SB episodes.  Six beats during 
was chosen for this model since the average length of an SB episode was six seconds. This 
value ensured maximum SB episode inclusion without omitting BP peak values in any SB 
episodes.  Baseline BP was established by averaging the first 7 beats (-20) to (-14) as 
replicated by Pennestri et. al., 2007 (1), to avoid contaminating the baseline calculations 
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with the heart rate changes known to precede SB.  SBP and DBP changes were calculated 
for each SB category for each subject, as depicted in Figure 1.1.   
2.3.7 Statistical Analysis 
SB related SBP and DBP changes were analysed using repeated measure analysis of 
variance (ANOVA) followed by planned comparisons, where all SBP and DBP values 
(beats -20 to +23) were compared to baseline (beats -20 to -14).  This analysis identified if 
and when a significant BP difference was present in SB.  A multilevel analysis was used to 
assess if a group difference existed between the four SB categories.  The advantage of using 
a multilevel statistical approach was that all subjects could be included in the analysis even 
if they did not present all four SB categories because this modeling allows for the 
accommodation of multiple missing data points (149).  Paired t-tests were also carried out 
to compare the SBP and DBP increments, in pairs, between the four SB categories.  
However, since few subjects had SB episodes in all four SB categories (refer to Table 3), 
the number of subjects qualifying for each paired t test was limited (between 3 – 5 subjects 
per test).  Therefore, the paired t tests were used mainly to compare and reinforce results 
obtained from the multilevel analysis.  A cut off p value of 0.05 was considered statistically 
significant. 
2.4 RESULTS 
All ten subjects were normal sleepers presenting an average sleep efficiency of 
93%.  The average RMMA index was 5.3 RMMA/hr (range 1.34 – 13.45). A detailed 
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summary of PSG data including RMMA, respiratory, and arousal indices are provided on 
Table 2.  The SB categories were evenly distributed (19-23 episodes each) except for the 
SB alone category which consisted of 4 episodes.  Two subjects displayed all four 
categories of SB.  The breakdown between subject and SB category distribution is listed on 
Table 3.  
2.4.1 BP Changes with SB Episodes   
There was an increase in BP for all SB categories and this rise was significant for 
SB + arousal, SB +body movement and SB + arousal + body movement.  The average 
increases of SBP and DBP for each SB category are displayed in Table 4, as well as the 
overall group effect.  The onset of the significant BP surge occurred before SB onset for SB 
+ arousal, and post SB onset for categories: SB + body movement and SB + arousal + 
body movement; the exact times with respect to SB onset are listed on Table 5 and can also 
be viewed graphically on Figures 1.3 and 1.4.  All BP peaks occurred after SB onset for all 
four SB categories.  All DBP measures returned to baseline within the 43 beat temporal 
window.  SBP never returned to baseline and actually remained significantly above 
baseline after reaching peak measures for the duration of the analyzed temporal window.   
In addition, subsample analysis showed no relation between the SB burst EMG 
amplitude, as measured by Root Mean Square (RMS), and the amplitude of BP surge (p = 
0.4). 
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2.4.2 Differences in BP Increments between SB Categories 
Due to the small number of SB alone episodes the BP surge comparison between 
the SB categories is focused on the SB categories with associated events: SB + arousal; SB 
+ body movement; SB + arousal + body movement first.  The SB alone category is 
incorporated as a separate analysis to provide preliminary comparisons.   
Multilevel analysis showed that there was no significant difference for both SBP 
(p=0.42) and DBP (0.17) between the 3 SB categories with events: SB + arousal, SB + 
body movement, and SB + arousal + body movement (Table 4).  There was however a trend 
showing a difference between SB + arousal and SB + body movement for DBP (p=0.07) 
(Table 6). Paired t tests comparison also showed no significant differences between these 3 
SB categories with the exception of the SBP between SB + arousal and SB + body 
movement (p=0.05) (Table 6).   
When incorporating the SB alone category into the multilevel analysis an all around 
significant difference between the four SB categories is revealed for both SBP (p=0.01) and 
DBP (p=0.02) measures (Table 4).  More specifically, the BP values for the SB alone 
episodes were significantly lower from the SB + arousal (SBP p=0.00; DBP trend: p=0.07), 
SB + body movement (SBP p=0.00; DBP p=0.00), and SB + arousal + body movement 
(SBP p=0.00; DBP p=0.02).   Further, SB + arousal had a significantly lower DBP 
(p=0.05) than SB + body movement. Comparable findings were made when using paired t 
tests except that the SB alone and SB + arousal categories showed no significant difference 
in either SBP (p=0.18) or DBP (p=0.51). 
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2.5 DISCUSSION 
The analysis supported the first hypothesis that SB is associated with a significant 
increase in both systolic and diastolic BP.   Further, data showed that this increase was 
significant for SB associated with cortical arousals, body movements, and cortical arousal 
with body movement.  An increase in BP was seemingly associated with SB alone but 
because of the low number of events (n=4) these data are not conclusive.  Analyses on this 
variable are currently on going.  These results are congruent with the autonomic changes 
currently known to precede SB, notably the augmentation in sympathetic activity followed 
by increases in EEG activity and heart rate, as well as respiratory changes.  Interestingly, 
the DBP returned to baseline within 23 beats post SB onset (Fig. 4), whereas, on the 
contrary, the SBP never returned to baseline following its peak within the same temporal 
window (Fig. 5).  This was consistent in all SB categories.  Why DBP and SBP did not 
follow the same physiological pattern in association with SB events is not clear. Previous 
work in our laboratory has shown that sympathetic activity, assessed using spectral analysis 
of mean cardiac RR intervals, remains above baseline for 28 minutes following an SB event 
(112).  Further, SBP have been reported to remain significantly above baseline for 40 
seconds following a cortical arousal (150).  Therefore, it is possible that sympathetic 
activation associated with sleep arousal and SB might variably affect cardiac and vascular 
responses, with a rapid normalization of peripheral vascular resistance as reflected by a 
rapid normalization of DBP, and a more sustained effect on cardiac contractility leading to 
  
49
 
a delayed SBP normalization. However, at present these hypotheses remain speculations 
that need further investigations.  
The onset of the significant BP surge varied depending on whether SB events were 
associated with arousals or body movements (Table 5).  However, this may have been an 
effect of where the arousals or body movements began in relation to the SB onset.   
 The exact cause of the SB related BP surge is not yet clear.  When considering both 
the results of this study and current literature it is difficult to conclude if the BP surge is a 
result of: a) SB/RMMA; b) the associated arousal; c) a combination of both events; d) an 
undetermined factor.  This is partly because it is still uncertain whether a significant BP 
surge is actually associated with a SB alone event, due to the small sample of SB episodes 
in that category.  Even if this does prove true, however, there is evidence that a hierarchical 
response exists in arousals, where an autonomic response is present even when EEG 
activity is not visible, and this response is associated with increase in BP (135;151).  
Therefore, in the absence of cortical activity, a subcortical arousal could still be present 
during SB episodes, contributing to the BP surge.   
To gain insight into the potential cause of this BP surge a subsample analysis was 
performed to examine the relationship between the EMG amplitude of the SB burst and the 
magnitude of the BP rise.  No correlation was found between these two variables which 
suggest that the BP rise may be attributed to a variable other than SB burst activity.   
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Clinically, the main concern raised from this study is whether the BP increments, or 
the potentially sustained SBP related to SB, pose an independent or cumulative risk for 
cardiovascular disease in either healthy and/or vulnerable populations.  Such a risk could 
present itself in certain populations if the SB related BP surge is found to significantly 
contribute to BP variability during sleep, since there is evidence that shows that BP 
variability is an independent predictor for cardiovascular disease in elderly individuals as 
well as those with type 2 diabetes (152).  Alternatively, SB’s association with cortical 
arousal could also raise cardiovascular health concerns since arousals that co-occur with 
sleep disordered breathing (SDB) have been shown to have adverse affects on the 
cardiovascular system (153-155). However, arousals associated with SB differ from those 
in SDB in that they have not been shown to be detrimentally repetitive, or affect sleep 
macrostructure, or disrupt sleep quality.   Nevertheless, further investigation is clearly 
required to determine the effects of SB on long term cardiac health in these subjects.   
With respect to our second hypothesis there is evidence that the BP rise associated 
with SB is significantly different depending on whether SB episodes are associated with 
arousals and/or body movements.  Although multilevel analysis showed no overall 
significant difference between BP surges in the three SB categories: SB + arousal; SB + 
body movement; SB + arousal + body movement, both multilevel analyses and paired t tests 
did show that SB + movement were associated with a significantly higher BP surge than SB 
+ arousal for at least one BP measure (either SBP or DBP) (Table 6).  With inclusion of SB 
alone episodes, multilevel analysis showed that SB alone episodes generated significantly 
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lower BP surges compared to SB that occurred with either arousals and/or body 
movements.  
Interestingly, SB episodes that were associated with both arousals and body 
movements generated a lower BP surge than SB episodes associated with only arousal or 
body movement; although these differences were not significant. Ongoing data collection 
and future analysis could shed more light on this observation.   
Thus, based on the consensus of both multi level and paired t tests analyses there is 
evidence that SB related BP surges do significantly vary depending on the events 
associated with SB.  These results suggest that SB + body movement may be associated 
with higher BP surges compared to SB + arousal and SB alone.  Owing to the small sample 
size, more data is required to confirm this observation as well as determine if a significant 
BP difference exists between SB alone and SB + arousal since paired t tests showed no 
difference between these categories for either SBP or DBP.  
The main limitation of this study was the sample size of single SB episodes, 
especially within the SB categories.  Further, no controls were used in this research so it is 
not known whether a similar BP surge occurs in control subjects exhibiting RMMA.  
Results obtained from this study are limited to single SB episodes occurring in stage 2 sleep 
only, that are experienced by young, healthy patients.  Caution should be made if 
extrapolated to SB events occurring in other sleep stages, particularly REM, as well as to 
SB clusters or vulnerable populations without further research. 
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 In continuation of this research a BP analysis involving a larger sample size of 
single SB episodes, SB clusters, and the incorporation of SB related breathing changes are 
currently ongoing.  In addition, future research should aim to conduct more control studies 
on the sympathetic and cardiovascular responses between subjects with SB and controls, to 
verify if the BP surges associated with SB/RMMA differ between these two groups.  This 
information could offer insight as to whether SB contributes to increased risk of 
hypertension or cardiovascular disease.  Long term studies are also necessary to assess if 
the BP changes associated with SB significantly impact the cardiovascular system over 
time, especially in vulnerable populations, such as patients with RLS, diabetes, and the 
elderly. 
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Table 1: Subject Demographics and Baseline BP during Wake 
Age (years) 26 ± 1.8 
BMI 23 ± 0.9 
Male : Female (ratio) 5 : 5 
Brachial SBP (mm Hg) 122 ± 2.1 
Brachial DBP (mm Hg) 67 ± 2.3 
All values are in mean ± Standard Error (SE) unless otherwise indicated 
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Table 2:  PSG Summary with RMMA, PLSM, Cortical Arousal, and Respiratory Indices 
Sleep Latency (minutes) 8.7  ±  1.3  (2.7 – 25) 
Total Sleep Time (minutes) 413.2  ±  13.9  (220.3 – 522.3) 
Sleep Efficiency (%) 92.9  ± 1.3  (79.1 – 99.4) 
Stage 1 (%) 6.9  ±  1.2  (2.0 –  24.0) 
Stage 2 (%)  52.2  ±  1.7  (2.0 –  72.5) 
Stage 3/4 (%) 22.1  ± 1.3  (12.4 –  38.0) 
Stage REM (%) 18.9  ±  0.7  (9.2 – 30.8) 
RMMA Index 5.3  ±  0.7  (1.3 – 13.5) 
Average RMMA Duration (seconds) 5.8  ±  0.3  (3.7 – 8.6) 
Arousal index 15.2  ±  1.4  (4.1 – 25.6) 
Average Arousal Duration (seconds) 6.6  ±  0.2  (6.4 – 7.8) 
Apnea - Hypopnea Index 0.4  ±  0.1  (0.0 – 2.5) 
*PLMS Index  1.1  ±  0.6  (0.0 – 8.8) 
**PLMS Index for subjects X and Y 18.3  ±  6.5  (5.4 – 30.9) 
PSG values are in mean ± SE (range);  
*Excluding 2 subjects (X and Y) who had PLMS (PLMS index > 5) 
**PLMS index of subjects X and Y who had PLMS only 
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Table 3: Distribution of Single SB Episodes Selected for each Subject 
 SB Category 
Patient# SB + Arousal SB + Body 
Movement 
SB + Arousal 
+ Body 
Movement 
SB Alone Total 
1 0 2 2 1 5 
2 5 5 2 1 13 
3 3 2 2 0 7 
4 6 0 0 1 7 
5 1 0 3 0 4 
6 0 3 4 0 7 
7 0 0 2 0 2 
8 0 8 0 0 8 
9 3 3 2 1 9 
10 1 0 2 0 3 
Total 19 23 19 4 65 
All episodes were in stage 2 sleep and consisted of single episodes only 
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Table 4:  Mean SDP and DBP Increase from Baseline for each SB Category, and Overall 
Group Effect 
 SB + 
Arousal 
SB + Body 
Movement 
SB + Arousal 
+ Body 
Movement  
SB Alone Group 
Effect 
without 
SB alone
Group 
Effect 
with SB 
alone 
Mean SBP 
↑ (mm Hg) 
28.4 ± 2.4 
 
30.7 ±1.6 
 
26.4 ±2.8 
 
22.9 ± 
5.2 
 
P = 0.42 
NS 
P = 0.01 
Mean DBP 
↑ (mm Hg) 
13.2 ± 1.5 
 
19.3 ± 2.3 
 
14.6 ± 2.0 
 
12.4 ± 
3.3 
 
P = 0.17 
NS 
P = 0.02 
BP values are shown as mean ± SE 
NS = None Significant 
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Table 5:  Start, Peak, and End of Significant BP Increase in Relation to SB Onset for Each 
SB Category 
 SB + Arousal SB + Body 
Movement 
SB + Arousal + 
Body 
Movement 
SB Alone 
Start of 
significant SBP ↑ 
2 beats post 
(p=0.02) 
4 beats pre 
(p=0.03) 
5 beats pre 
(p=0.03) 
NS 
Start of 
significant DBP ↑ 
Start of SB 
onset (p=0.03) 
5 beats pre 
(p=0.02) 
4 beats pre 
(p=0.02) 
NS 
SBP Peak 6 beats post 
(p=0.00) 
4 beats post 
(p=0.00) 
3 beats post 
(p=0.00) 
________ 
DBP Peak 7 beats post 
(p=0.00) 
4 beats post 
(p=0.00) 
6 beats post 
(p=0.00) 
________ 
End of significant 
SBP ↑ 
N/A N/A N/A ________ 
End of significant 
DBP ↑ 
11 beats post 
(p=0.00) 
12 beats post 
(p=0.03) 
11 beats post 
(p=0.01) 
________ 
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Table 6: Difference in BP Surges between the SB Categories :  Multilevel Analysis and 
Paired T Test Results 
Multilevel Analysis Paired t test SB Category Comparisons 
SBP DBP SBP DBP 
SB  + Arousal      vs.  
SB + Body Movement 
NS 
(p=0.46) 
Trend 
(p=0.07) 
Significant 
(p=0.05) 
NS 
(p=0.25) 
SB + Arousal      vs. 
SB + Body Movement + Arousal 
NS 
(p=0.60) 
NS 
(p=0.52) 
NS 
(p=0.59) 
NS 
(p=0.51) 
SB + Body Movement      vs. 
SB + Body Movement + Arousal 
NS 
(p=0.22) 
NS 
(p=0.14) 
NS 
(p=0.57) 
NS 
(p=0.25) 
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Figure 1.1 BP Increase associated with SB 
 
Figure 1.1. Sample of the 43 beat temporal window used for beat to beat BP analysis during an SB episode.  
The vertical line depicts SB onset as detected by the RM signal (Right Masseter EMG). The beat to beat blood 
pressure increase is represented by the BP signal.  Additional signals included ECG, EGO, SANT and EEG. 
 
 
 
 
  
60
 
 
Figure 1.2. Changes in DBP in the four SB Categories 
Vertical line represents SB onset;  
(*) represent statistical significance p≤0.05 
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Figure 1.3.  Significant increases in DBP compared to baseline were observed in the SB categories: SB + 
arousal; SB + body movement; SB + body movement + arousal.  
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Figure 1.3.  Changes in SDP for the four SB Categories 
Vertical line represents SB onset; 
 (*) represent statistical significance p≤0.05 
 
 
 
Figure 1.4.  Significant increases in SBP compared to baseline were observed in the SB categories: SB + 
arousal; SB + body movement; SB + body movement + arousal. Once increased, SBP remained statistically 
significant for the duration of the analyzed temporal window. 
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CHAPTER 3: DISCUSSION 
This study documented that SB is associated with a rise in systolic and diastolic BP 
and that these increases are statistically significant for SB with arousals, SB with body 
movements, and SB with arousals and body movements. Due to the small number of events 
of SB occurring alone (n=4), the BP increase for this group remains inconclusive. In 
support of our first hypothesis results from this study suggest that when changes occur in 
the autonomic system in association with SB, a rise blood pressure is concomitant.    
Interestingly, after attaining peak values the SBP and DBP did not return to baseline 
at the same time following the SB events, an observation that was consistent in all SB 
categories.  The DBP returned to baseline within 12 beats following SB onset.  In contrast, 
SBP remained significantly above baseline for the duration of the analysed temporal 
window (Table 5).  The reason for this observation is unknown.  Studies in our laboratory 
have shown that the sympathetic system, assessed using spectral analysis of RR cardiac 
intervals, are associated with sustained activity lasting 28 minutes after an SB episode 
(112).  Similar findings have been made in BP surges associated with cortical arousals, 
where SBP and the low frequency component of heart rate variability were shown to 
remain significantly above baseline for 40 seconds following a cortical arousal event (150).  
More research is required to understand why the two BP measures exhibit different 
patterns.  A possible explanation could be that the sympathetic activities that precede SB 
and cortical arousals have different cardiac versus vascular effects.  Specifically, peripheral 
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vascular resistance may normalize rapidly, reflecting DBP’s rapid return to baseline values, 
yet sympathetic effects on cardiac contractility remain sustained causing SBP to stay 
elevated above baseline for a longer duration.  
The start of the significant BP rise varied depending on whether SB events were 
associated with either arousals or body movements.  Particularly for SB + arousal the 
significant BP surge began after SB onset. In contrast, for SB + body movement and SB + 
arousal + body movement exhibited the significant BP surge began before SB onset.  These 
observations, however, may have been an effect of when the arousals and body movements 
occurred in relation to SB onset.   
The cause of the BP surge associated with SB is still unknown.  We performed a 
subsample analysis to identify if the EMG amplitude of the SB bursts were correlated with 
the magnitude of the BP surge and no correlation was found suggesting that the SB related 
BP rise is attributed to a variable other than SB burst activity.  Results from a previous 
study in our laboratory showed that BP surges related to PLMS were positively correlated 
to the duration of associated cortical arousals, independent of PLMS characteristics (1).  In 
addition, cortical arousals occurring in isolation have been shown to generate a BP surge 
75% of which is normally seen in an obstructive apneic event (events which are usually 
associated with arousals) (151).  Thus, it is clear that arousals are associated with 
autonomic responses that correspond to BP surges.  Given that SB often co occurs with 
cortical arousals, it is possible that the BP surge associated with SB could be attributed, 
even partly, to the SB associated EEG activity.  Unfortunately this study did not generate a 
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large enough sample of SB alone episodes to adequately compare the BP surges occurring 
in SB + arousal to SB alone, which would have offered more insight into this hypothesis.  
It is important to consider that arousals absent of EEG activity are also associated with 
autonomic responses that generate increases in BP.  It is uncertain whether or not these 
types of arousals are present in all SB events, contributing to the cause of the BP surge.   
The clinical relevance of the BP surge associated with SB is not entirely certain.  To 
our knowledge no studies have yet examined the long term effects of SB on cardiovascular 
health.  Further, there have been no studies examining the BP surges related to SB/RMMA 
in SB subjects compared to controls.  SB could contribute to increased risk of 
cardiovascular disease in some populations if the related BP surges contribute to increased 
BP variability during sleep, since there is evidence that increased BP variability during 
sleep is an independent predictor for cardiovascular disease in patients with Type 2 diabetes 
(152).  Yet, at the present time this remains unknown and requires further investigation.   
Alternatively, since SB is associated with arousals and repetitive cortical arousals 
have been shown to adversely affect the cardiovascular system (153;155), perhaps the 
arousals associated with SB could potentially contribute to increased cumulative 
cardiovascular risk. There is evidence that repetitive cortical arousals associated with 
obstructive sleep apnea (OSA) prevent the BP cardiac protective “dipping” that normally 
occurs in sleep (156), and evidence suggests that this is a result specifically of the BP 
elevations generated from these arousals (155).  Contrary to OSA, however, EEG arousals 
associated with SB have not been shown to disrupt sleep macrostructure, or be repetitive in 
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a manner that affects sleep quality.  Nevertheless, it remains unknown whether SB’s 
association to arousal contribute to increased risk of cardiovascular disease.   
When comparing the mean BP surges of the 3 SB categories: SB + arousal; SB + 
body movement; SB + arousal + body movement, both paired t tests comparisons and 
multilevel analyses showed that SB + movement are associated with a significantly higher 
BP surge than SB + arousal for at least one BP measure (either SBP or DBP).  When 
including SB alone episodes, multilevel analysis showed that SB alone episodes generated a 
significantly lower BP surge than SB episodes occurring with either arousals and/or body 
movements.  
Interestingly, when SB was associated with both arousals and body movements it 
generated a lower mean BP surge compared to when SB was associated with just one of 
these events, although this difference was not significant.  Further, through observational 
data this study found that on occasion the BP actually decreased in relation to SB.  These 
observations were found mostly during SB clusters, which were not incorporated in this 
analysis.  The decreases in BP were often accompanied by a number of associated events 
such as cortical arousals, body movements, and respiratory changes, particularly large 
respiratory efforts.  Ongoing data collection and future analysis may provide more insight 
into these observations. 
Therefore, in relation to our second hypothesis, both the multilevel analysis and 
paired t tests provide evidence that SB related BP surges do significantly vary depending on 
the events associated with SB.  Specifically, these data suggest that SB + body movement 
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may be associated with higher BP surges compared to SB + arousal and SB alone (Table 
4).  Owing to the small sample size of single SB events more data is required to confirm 
these observations, as well as determine if a significant BP difference exists between SB 
alone and SB + arousal, since paired t tests showed no difference between these categories 
for either SBP or DBP.  
The main limitation of this study was the sample size of single SB episodes, 
especially within the SB categories, and the SB alone category in particular.  Results 
obtained from this study are limited to single SB episodes occurring in stage 2 sleep only, 
that are experienced by young, healthy subjects.  Caution should be made if extrapolated to 
SB events occurring in other sleep stages, particularly REM, as well as to SB clusters or 
vulnerable populations without further research. Furthermore, there were no controls used 
in this study to compare the BP fluctuations associated with RMMA to subjects with SB.   
In continuation of this research a BP analysis involving a larger sample size of 
single SB episodes is currently ongoing.  This will allow for greater control over variables 
such as timing and duration of associated events.  In addition, the effect of SB related 
breathing will be included since significant changes in respiration are often associated with 
SB and can significantly impact BP. As well, analysis will be extended to SB clusters, 
which comprises 75% of all SB episodes (97). These studies will consist of a larger 
temporal window for each SB episode to determine if and when the SBP returns to baseline 
following SB onset.  Additionally, future research should aim to conduct more control 
studies assessing the sympathetic and cardiovascular responses between SB subjects and 
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controls, as well as verify if the BP surges associated with RMMA differ between these 
groups.  These studies would offer insight as to whether SB contributes to increased risk of 
hypertension or cardiovascular disease.  Long term studies are necessary to assess if the SB 
related BP fluctuations significantly impact cardiovascular function over time.  Lastly, 
research should extend to vulnerable populations, including subjects with RLS, diabetes, 
and the elderly.   
 
 
 CHAPTER 4: CONCLUSION 
In summation, the present analysis supports the hypothesis that sleep bruxism is 
associated with an increase in blood pressure, and this increase is significant when SB is 
associated with arousals and/or body movements.  These results are congruent with the 
current physiological sequences known to precede SB genesis.  There was evidence that the 
BP does vary depending on whether SB occurs with arousals, body movements, or alone.   
More precisely, preliminary evidence from this study suggests that SB occurring with body 
movements is associated with a higher BP surge than SB occurring with arousals, or alone.  
The exact cause of the BP surge is still unknown, as well as why only SBP, and not DBP, 
remained elevated after SB onset.   
Therefore, results from this study have generated new queries and ideas for future 
research.  In continuation of this research ongoing analysis will incorporate a larger sample 
size of single SB episodes and will conduct a separate analysis on BP fluctuations in 
relation to SB clusters.  As well, the SB temporal window for each episode will be 
expanded to determine how long SBP remains above baseline following an SB episode.  
Additional studies should examine sympathetic and cardiovascular changes in control 
versus SB subjects, and facilitate long term studies to assess the long term affects of SB on 
cardiovascular function.  Such analyses may contribute to the current physiological 
knowledge of SB, and provide information clinically relevant to the health of SB subjects.
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